PREOB®-ON3 - A bone cell therapy for hip osteonecrosis

• Research type

  Research Study

• Full title

  Phase III, pivotal, multicentre, randomised, double-blind controlled Study to evaluate the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB®) Implantation in Early Stage Non Traumatic Osteonecrosis of the Femoral Head

• IRAS ID

  129966

• Contact name

  Andrew McCaskie

• Contact email

  awm41@cam.ac.uk

• Sponsor organisation

  Bone Therapeutics S.A.

• Eudract number

  2009-012929-11

• Clinicaltrials.gov Identifier

  NCT01529008

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  14/LO/0056

• Date of REC Opinion

  4 Mar 2014

• REC opinion

  Further Information Favourable Opinion